Breast Cancer clinical trials
Showing 651–700 of 1,067 active trials. Describe your situation to see which ones you may be eligible for.
- Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
- Lymphedema Surveillance Study
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Core Biopsies for Establishing a Breast Tumor Tissue Repository
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- National Mammography Database
- Prospective Screening for Breast Cancer-related Lymphedema
- The Immune System's Response to Young Women's Breast Cancer
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
- Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
- Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
- Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
- ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
- Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
- Safe and Explainable AI
- SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Apple Women's Health Study
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
- Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
- Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Intratumoral N17350 in Advanced Solid Tumors
- Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
- Sample Collection for Ongoing Research and Product Evaluation Study
- EXoPERT EMERALD Clinical Study
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- BostonGene and Exigent Genomic INsight Study
- Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.